Latest Industry News

All

Novartis Invests $23 Billion in U.S. Manufacturing: A Game-Changer for Domestic Drug Production

Novartis Invests $23 Billion in U.S. Manufacturing: A Game-Changer for Domestic Drug Production

FDA Reverses Full-Time Office Mandate: Remote Work Flexibility Takes Center Stage

FDA Reverses Full-Time Office Mandate: Remote Work Flexibility Takes Center Stage

Brace for Impact: How Trump's Potential Pharma Tariffs Could Transform Drug Pricing and Distribution

Brace for Impact: How Trump’s Potential Pharma Tariffs Could Transform Drug Pricing and Distribution

Trump's Tariff Pause: What It Means for Global Trade and the U.S. Economy

Trump’s Tariff Pause: What It Means for Global Trade and the U.S. Economy

Federal Appeals Court Clears Way for HHS to Terminate Probationary Employees: What It Means for Job Security in Government

Federal Appeals Court Clears Way for HHS to Terminate Probationary Employees: What It Means for Job Security in Government

Unlocking Access: ICER's Game-Changing Solutions for Affordable GLP-1 Medications in Obesity Treatment

Unlocking Access: ICER’s Game-Changing Solutions for Affordable GLP-1 Medications in Obesity Treatment

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Novartis Invests $23 Billion in U.S. Manufacturing: A Game-Changer for Domestic Drug Production

Novartis Invests $23 Billion in U.S. Manufacturing: A Game-Changer for Domestic Drug Production

FDA Reverses Full-Time Office Mandate: Remote Work Flexibility Takes Center Stage

FDA Reverses Full-Time Office Mandate: Remote Work Flexibility Takes Center Stage

Brace for Impact: How Trump's Potential Pharma Tariffs Could Transform Drug Pricing and Distribution

Brace for Impact: How Trump’s Potential Pharma Tariffs Could Transform Drug Pricing and Distribution

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA